CIK 0001267565 · Large accelerated filer
COLLEGIUM PHARMACEUTICAL, INC
Sign in to watch- Ticker
- COLL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- Phone
- 781-713-3699
- Business address
- 100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA, 02072
- Former names
- COLLEGIUM PHARMACEUTICAL INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-14 | BOHLIN GAREN G Director | Sale | −28,985 | $32.30 | $936K | 44,775 |
| 2024-05-14 | BOHLIN GAREN G Director | Option exercise · Stock Option (Right to Purchase) | −28,985 | 0 | ||
| 2024-02-29 | Smith Thomas B EVP and Chief Medical Officer | Sale | −995 | $36.76 | $37K | 63,409 |
| 2024-02-26 | Dreyer Scott EVP & Chief Commercial Officer | Sale 10b5-1 | −9,336 | $36.38 | $340K | 139,582 |
| 2024-02-26 | Dreyer Scott EVP & Chief Commercial Officer | Sale 10b5-1 | −664 | $37.15 | $25K | 138,918 |
| 2024-02-12 | Tupper Colleen EVP & Chief Financial Officer | Grant or award | +40,600 | 146,020 | ||
| 2024-02-12 | Tupper Colleen EVP & Chief Financial Officer | Grant or award | +30,856 | 176,876 | ||
| 2024-02-12 | Tupper Colleen EVP & Chief Financial Officer | Shares withheld for taxes | −16,868 | $33.70 | $568K | 160,008 |
| 2024-02-12 | Tupper Colleen EVP & Chief Financial Officer | Shares withheld for taxes | −9,453 | $33.70 | $319K | 150,555 |
| 2024-02-12 | Dreyer Scott EVP & Chief Commercial Officer | Grant or award | +35,000 | 146,322 | ||
| 2024-02-12 | Dreyer Scott EVP & Chief Commercial Officer | Grant or award | +32,286 | 178,608 | ||
| 2024-02-12 | Dreyer Scott EVP & Chief Commercial Officer | Shares withheld for taxes | −19,545 | $33.70 | $659K | 159,063 |
| 2024-02-12 | Dreyer Scott EVP & Chief Commercial Officer | Shares withheld for taxes | −10,145 | $33.70 | $342K | 148,918 |
| 2024-02-12 | Smith Thomas B EVP and Chief Medical Officer | Grant or award | +30,800 | 62,980 | ||
| 2024-02-12 | Smith Thomas B EVP and Chief Medical Officer | Grant or award | +4,623 | 67,603 | ||
| 2024-02-12 | Smith Thomas B EVP and Chief Medical Officer | Shares withheld for taxes | −1,899 | $33.70 | $64K | 65,704 |
| 2024-02-12 | Smith Thomas B EVP and Chief Medical Officer | Shares withheld for taxes | −1,300 | $33.70 | $44K | 64,404 |
| 2024-02-12 | Kuhlmann Shirley R. EVP and General Counsel | Grant or award | +43,400 | 162,918 | ||
| 2024-02-12 | Kuhlmann Shirley R. EVP and General Counsel | Grant or award | +33,247 | 196,165 | ||
| 2024-02-12 | Kuhlmann Shirley R. EVP and General Counsel | Shares withheld for taxes | −21,146 | $33.70 | $713K | 175,019 |
Page 8 of 24 · 462 trades